Recent landmark trials, particularly the SELECT study, have provided compelling evidence for cardiovascular benefits in non-diabetic obese patients, potentially reshaping our understanding of obesity treatment paradigms
The FDA had issued boxed warnings for other medications based on preclinical data that were later contradicted by large-scale clinical trials
Addressing Metabolic Dysfunction as an Independent Cancer Risk Factor Accumulating evidence positions metabolic dysfunction characterised by insulin resistance, hepatic steatosis, dyslipidaemia, and visceral adiposity as a more powerful and proximate predictor of cancer risk than elevated body weight alone
Monthly $179/mo 2.5mg/5mg vial billed monthly All treatments include: High potency, 3rd party lab tested Personalized protocols from licensed physicians Free discreet shipping every order Ongoing provider support & check-ins Get started Best Value Quarterly $149/mo 2.5mg/5mg vial billed every 3 months Everything in monthly, plus: Priority shipping & processing Dedicated care coordinator Complimentary dosage adjustments Save up to 15% vs monthly billing Get started Patient Stories There's a reason people are raving about us Join thousands of patients who have trusted Zera Health to transform their lives
Metformin HCl In clinical trials with metformin HCl immediate-release tablets in pediatric patients with type 2 diabetes mellitus, the profile of adverse reactions was similar to that observed in adults
